Abstract
Background and aims: Merkel Cell Carcinoma (MCC) is a rare, aggressive neuroendocrine cutaneous malignancy with rising incidence. Since MCC is predominantly diagnosed in White patients, limited data is available regarding baseline presentation, treatment patterns, and survival for Black MCC patients. Our aim was to address this gap by identifying racial differences in the MCC patient population. Methods: We conducted a retrospective cohort analysis comparing White and Black MCC patients from 2006-2017 using the National Cancer Database.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
